Cartalax 20 mg

Cartalax is a synthetic tripeptide bioregulator built from the short amino-acid sequence Ala-Glu-Asp. It comes out of the Khavinson school of peptide research and is best known for its use in cartilage and connective-tissue research models.

It sits within a wider body of short-peptide bioregulator work exploring how very small sequences interact with tissue (Khavinson & Anisimov, 2009, Adv Gerontol). That background is why it turns up as a reference peptide in connective-tissue studies.

Research Applications

• Cartilage and connective-tissue research
• Short peptide bioregulator studies
• Tissue-interaction research models
• Minimal-sequence peptide research

Supplied as a lyophilized powder for stability.

See also: Cardiogen 20 mg, Cortagen 20 mg, and Livagen 20 mg.

$21

Cartalax 20 mg Structure

Peptide Class: Short peptide bioregulator (Khavinson-school)
Amino Acid Sequence: Ala-Glu-Asp (AED)
Molecular Formula: C₁₂H₁₉N₃O₈
Molecular Weight: ~333.29 g/mol
CAS Number: N/A
PubChem CID: 87815447
Synonyms: Alanyl-glutamyl-aspartic acid; T-31 peptide

$22

$23